Exploring the 24h-effect of targeted therapies in non-small cell lung cancer from exon array blood profiling using dually constrained correspondence analysis Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Single Slide Assessment: the future of molecular testing in lung cancer? Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017
Lung cancer: only tobacco-smoking? Source: Annual Congress 2004 - Occupational Grand Round, an interactive session Year: 2004
Determining genomic rearrangements in clinical lung specimens for assessment of metastatic disease, actionable targets and disease monitoring Source: International Congress 2016 – New genomic targets in pulmonary disease Year: 2016
ERS School Course Early-stage lung cancer - What's new in the epidemiology of lung cancer: the female aspect Source: ISSN=ISSN 1810-6838, ISBN=, page=339 Year: 2006
A functional polymorphism in XRCC1 gene is associated with lung cancer risk in a Korean population Source: International Congress 2014 – Pathology and prognostic factors of thoracic tumours Year: 2014
Metabolic modification as a potential therapeutics approach in lung cancer Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life Year: 2013
Biomarkers in early-detection of lung cancer: current concepts Source: Virtual Congress 2021 – Biomarkers in early-detection of lung cancer: current concepts Year: 2021
Population’s understanding and degree of participation of a screening lung cancer programme Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Epidemiology of lung cancer: the novelties Source: Annual Congress 2006 - PG19 - Thoracic oncology: diagnostic assessment of lung cancer Year: 2006
Exploiting metabolomic approaches to aid in the diagnosis of lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Defining lineage relationships of multiple lung tumors through shared large genomic rearrangements Source: Annual Congress 2013 –New strategies in epigenomic research to study lung diseases (DNA rearrangements, RNA, methylation, proteosome) Year: 2013
Lung cancer - are we ageist? Source: Eur Respir J 2003; 22: Suppl. 45, 253s Year: 2003
Epigenetic alterations in the circulating DNA from blood of patients with COPD and lung cancer Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Lung cancer screening - what does it mean for our practice? Source: Virtual Congress 2020 – Screening and imaging in lung cancer Year: 2020
Telomere-associated gene network in lung adenocarcinoma Source: International Congress 2015 – Respiratory translational research: novel mechanisms, diagnostic markers and Space Odyssey Year: 2015
Novel survey tool used to assess priorities of lung cancer patients and carers Source: International Congress 2015 – Quality management in lung cancer Year: 2015